-
Maximum Efficacy
We help you identify the right target, indication & patient population.
-
-
-
We are a boutique consulting firm working at the intersection of life sciences and finance.
Conceived at The Wharton School (University of Pennsylvania) in the late 90s, we serve all private and public entities involved in the life sciences – including biotech and pharma companies, investment funds, and other organizations. At the time of our inception, we were pioneers in our field. Foundational papers authored by our co-founders now form the cornerstone of valuation methods taught at the world’s leading business schools. Today, we’ve evolved into a full-grown service provider addressing the needs of all organizations active in the life sciences.
Services
We serve all entities involved in the life sciences.
We help you choose the best target, indication, and patient population – to boost efficacy, minimize development risk, and maximize patient share.
Our valuations provide the basis for successful funding rounds, deal negotiations, mergers & acquisitions, and IPOs.
We can take care of the entire licensing process – starting with an elaborate asset valuation, we approach potential partners and execute the deal.
We can take care of the entire licensing process – starting with an elaborate asset valuation, we approach potential partners and execute the deal.
We analyze investment and in-licensing opportunities to maximize your return on investment.
Featured
Current Partnerships
We Sponsor
Our Partners
